[CDB] QoQ Annualized Quarter Result on 31-Mar-2011 [#1]

Announcement Date
29-Apr-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- 12.53%
YoY- 19.1%
View:
Show?
Annualized Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 5,963,954 5,891,374 5,797,122 5,722,252 5,406,457 5,302,393 5,250,908 8.83%
PBT 1,560,262 1,561,256 1,544,872 1,788,612 1,597,248 1,529,252 1,512,990 2.06%
Tax -305,878 -414,377 -409,444 -463,028 -419,244 -401,281 -399,662 -16.28%
NP 1,254,384 1,146,878 1,135,428 1,325,584 1,178,004 1,127,970 1,113,328 8.25%
-
NP to SH 1,254,384 1,146,878 1,135,428 1,325,584 1,178,004 1,127,970 1,113,328 8.25%
-
Tax Rate 19.60% 26.54% 26.50% 25.89% 26.25% 26.24% 26.42% -
Total Cost 4,709,570 4,744,496 4,661,694 4,396,668 4,228,453 4,174,422 4,137,580 8.99%
-
Net Worth 1,399,808 1,306,570 1,244,304 1,345,810 1,345,179 1,399,595 1,383,885 0.76%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 1,360,925 1,140,656 1,135,427 1,338,030 1,267,423 1,244,085 1,088,449 16.01%
Div Payout % 108.49% 99.46% 100.00% 100.94% 107.59% 110.29% 97.77% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 1,399,808 1,306,570 1,244,304 1,345,810 1,345,179 1,399,595 1,383,885 0.76%
NOSH 7,776,714 777,720 777,690 777,924 777,560 777,553 777,463 362.29%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 21.03% 19.47% 19.59% 23.17% 21.79% 21.27% 21.20% -
ROE 89.61% 87.78% 91.25% 98.50% 87.57% 80.59% 80.45% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 76.69 757.52 745.43 735.58 695.31 681.93 675.39 -76.45%
EPS 16.13 147.47 146.00 170.40 151.50 145.07 143.20 -76.58%
DPS 17.50 146.67 146.00 172.00 163.00 160.00 140.00 -74.90%
NAPS 0.18 1.68 1.60 1.73 1.73 1.80 1.78 -78.20%
Adjusted Per Share Value based on latest NOSH - 777,924
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 50.84 50.22 49.41 48.78 46.08 45.20 44.76 8.83%
EPS 10.69 9.78 9.68 11.30 10.04 9.61 9.49 8.23%
DPS 11.60 9.72 9.68 11.41 10.80 10.60 9.28 15.99%
NAPS 0.1193 0.1114 0.1061 0.1147 0.1147 0.1193 0.118 0.73%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 3.88 3.04 2.90 2.86 2.46 2.43 2.30 -
P/RPS 5.06 0.40 0.39 0.39 0.35 0.36 0.34 502.06%
P/EPS 24.05 2.06 1.99 1.68 1.62 1.68 1.61 503.56%
EY 4.16 48.51 50.34 59.58 61.59 59.70 62.26 -83.45%
DY 4.51 48.25 50.34 60.14 66.26 65.84 60.87 -82.27%
P/NAPS 21.56 1.81 1.81 1.65 1.42 1.35 1.29 550.34%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 19/01/12 24/10/11 20/07/11 29/04/11 28/01/11 26/10/10 20/07/10 -
Price 3.88 3.16 2.98 2.91 2.53 2.47 2.37 -
P/RPS 5.06 0.42 0.40 0.40 0.36 0.36 0.35 490.57%
P/EPS 24.05 2.14 2.04 1.71 1.67 1.70 1.66 491.41%
EY 4.16 46.67 48.99 58.56 59.88 58.73 60.42 -83.11%
DY 4.51 46.41 48.99 59.11 64.43 64.78 59.07 -81.91%
P/NAPS 21.56 1.88 1.86 1.68 1.46 1.37 1.33 537.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment